Guidelines
Monday, November 18th, 2013
AHA: 11/12/13 Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular (CV) diseases, improve the management of people who have these diseases through professional education and research, and develop guidelines, standards and policies that promote optimal […]
Guidelines
Monday, November 18th, 2013
AHA: 11/12/13 Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular (CV) diseases, improve the management of people who have these diseases through professional education and research, and develop guidelines, standards and policies that promote […]
Guidelines
Monday, November 18th, 2013
AHA: 11/12/13 Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular (CV) diseases, improve the management of people who have these diseases through professional education and research, and develop guidelines, standards and policies that promote […]
Atrial Fibrillation
Monday, November 18th, 2013
JACC: 11/19/13 Objectives The aim of this study was to compare the prevalence of silent cerebral ischemia (SCI) and cognitive performance in patients with paroxysmal and persistent atrial fibrillation (AF) and controls in sinus rhythm. Background Large registries have reported a similar risk for symptomatic stroke in both paroxysmal and persistent AF. The relationship among paroxysmal and persistent AF, […]
Atrial Fibrillation
Monday, November 18th, 2013
AHA: November 15, 2013 Background—Atrial fibrillation (AF) ablation is an established therapy; however, limited data is available on associated complications. This systematic review determines the incidence and potential predictors of acute complications. Methods and Results—Electronic searches were conducted in MEDLINE and EMBASE for English scientific literature up to the 18th June 2012. 2065-references were retrieved and […]
Atrial Fibrillation
Monday, November 18th, 2013
CIRCULATIONAHA: November 13, 2013 Background—High sensitivity troponin-I (hs-TnI) measurements improves risk assessment for cardiovascular events in many clinical settings, the added value in atrial fibrillation (AF) patients has not been described. Methods and Results—At randomization hs-TnI was analyzed in 14,821 AF patients in the ARISTOTLE trial comparing apixaban with warfarin. The associations between hs-TnI concentrations and […]
Atrial Fibrillation
Monday, November 18th, 2013
CIRCOUTCOMES: November 12, 2013 Background—New anticoagulants may improve health outcomes in patients with atrial fibrillation, but it is unclear whether their use is cost-effective. Methods and Results—A Markov state transition was created to compare 4 therapies: dabigatran 150 mg BID, apixaban 5 mg BID, rivaroxaban 20 mg QD, and warfarin therapy. The population included those with […]
Atrial Fibrillation
Monday, November 18th, 2013
PLOS: 11/11/13 Autonomic fluctuations are associated with the initiation and possibly maintenance of atrial fibrillation (AF). However, little is known about the relationship between orthostatic blood pressure change, a common manifestation of autonomic dysfunction, and incident AF. Methods We examined whether supine-to-standing changes in systolic blood pressure (SBP) are associated with incident AF in 12,071 African […]
Clinical Trials
Monday, November 18th, 2013
JAMA: 11/17/13 Importance Although the benefit of reducing blood pressure for primary and secondary prevention of stroke has been established, the effect of antihypertensive treatment in patients with acute ischemic stroke is uncertain. Objective To evaluate whether immediate blood pressure reduction in patients with acute ischemic stroke would reduce death and major disability at 14 days or hospital […]
Clinical Trials
Monday, November 18th, 2013
ASA: 11/12/13 Atrial fibrillation (AF) is the most common type of arrhythmia in adults and becomes more common with increased age. Management of people with AF aims at preventing thromboembolic complications, and anticoagulant treatment with vitamin K antagonists (VKAs) has been the therapy of choice for many decades. A new class of anticoagulants, the factor Xa […]
